Research
-
Amyloidoses
- Age-Related Macular Degeneration
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Autism Spectrum Disorder
- Chronic Mental Diseases
- Chronic Traumatic Encephalopathy
- Conjunctival Amyloidosis
- Corticobasal Degeneration
- Creutzfeldt–Jakob Disease
- Dementia With Lewy Bodies
- Dentatombral-Pallidoluysian Atrophy
- Desmin-Related Cardiomyopathy
- Dialysis-Related Amyloidosis
- Familial Alzheimer’s Disease
- Familial Amyloidotic Cardiomyopathy
- Familial Amyloidotic Polyneuropathy
- Familial Amyotrophic Lateral Sclerosis
- Familial British Dementia
- Familial Danish Dementia
- Familial Fatal Insomnia
- Familial Mediterranean Fever
- Familial Oculoleptomeningel Amyloidosis
- Familial Parkinson’s Disease
- Finnish Hereditary Systemic Amyloidosis
- Frontotemporal Dementia
- Gerstmann–Sträussler–Scheinker Syndrome
- HIV Infection
- Hereditary Cerebral Amyloid Angiopathy
- Hereditary Non-Neuropathic Systemic Amyloidosis
- Hereditary Renal Amyloidosis
- Huntington’s Disease
- Inclusion Body Myositis
- Insulin-Related Amyloidosis
- Isolated Atrial Amyloidosis
- Medullary Carcinoma Of The Thyroid
- Multiple Systems Atrophy
- Parkinson’s Disease
- Pick’s Disease
- Preeclampsia
- Primary Amyloidosis
- Progressive Supranuclear Palsy
- Prostatic Amyloidosis
- Pure Autonomic Failure
- Senile Systemic Amyloidosis
- Spinal And Bulbar Muscular Atrophy
- Spinal Cord Injury And Traumatic Brain Injury
- Spinocerebellar Ataxia Types 1, 2, 3, 6, 7, And 17
- Systemic (Reactive) Aa Amyloidosis
- Type-2 Diabetes Mellitus
- Molecular Tweezers
- Biomarkers In Peripheral Biofluids
Current projects
An important focus of our lab is the analysis of biomarkers that can improve the prognosis and diagnosis of amyloidoses or proteinopathies and facilitate drug development for them. In this context, we are particularly interested in biomarker measurement in extracellular vesicles (EVs) originating in the CNS and isolated from peripheral biofluids, such as serum and plasma. We also study how EVs mediate the transfer of biological material among cells and the consequences of such delivery.
Another major project in our lab is the development of “Molecular Tweezers” as novel drug candidates for proteinopathies.